Mallinckrodt Pharmaceuticals is a $2.1 billion global pharmaceutical company specializing in generic and branded pharmaceuticals, medical imaging, nuclear imaging and contrast media and devices.
Mallinckrodt Pharmaceuticals is a $2.1 billion global pharmaceutical company specializing in generic and branded pharmaceuticals, medical imaging, nuclear imaging and contrast media and devices.
Mallinckrodt Pharmaceuticals is a $2.1 billion global pharmaceutical company specializing in generic and branded pharmaceuticals, medical imaging, nuclear imaging and contrast media and devices.
Mallinckrodt Pharmaceuticals is a $2.1 billion global pharmaceutical company specializing in generic and branded pharmaceuticals, medical imaging, nuclear imaging and contrast media and devices.
Mallinckrodt Pharmaceuticals is a $2.1 billion global pharmaceutical company specializing in generic and branded pharmaceuticals, medical imaging, nuclear imaging and contrast media and devices.
Mallinckrodt Pharmaceuticals is a $2.1 billion global pharmaceutical company specializing in generic and branded pharmaceuticals, medical imaging, nuclear imaging and contrast media and devices.